Novo Nordisk sues rival Eli Lilly over ‘misleading' weight-loss drug advertising

Novo Nordisk sues rival Eli Lilly over ‘misleading' weight-loss drug advertising
FacebookXWhatsAppEmail

Two of the world’s biggest pharmaceutical companies are headed to court after Novo Nordisk , the maker of Ozempic and a pioneer in diabetes and obesity treatments, sued rival Eli Lilly on Tuesday, accusing the U.S. drugmaker of false advertising. The Danish company filed the lawsuit in U.S. Distr...